WallStSmart

Ridgetech, Inc. (RDGT)vsScienture Holdings, Inc. (SCNX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ridgetech, Inc. generates 18256% more annual revenue ($119.94M vs $653,390). RDGT leads profitability with a 10.3% profit margin vs 0.0%. RDGT earns a higher WallStSmart Score of 34/100 (F).

RDGT

Avoid

34

out of 100

Grade: F

Growth: 2.7Profit: 3.0Value: 5.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.41

SCNX

Avoid

33

out of 100

Grade: F

Growth: 4.0Profit: 2.5Value: 8.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for RDGT.

SCNXUndervalued (+91.2%)

Margin of Safety

+91.2%

Fair Value

$5.10

Current Price

$0.46

$4.64 discount

UndervaluedFair: $5.10Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

RDGT1 strengths · Avg: 10.0/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

SCNX2 strengths · Avg: 10.0/10
P/E RatioValuation
0.7x10/10

Attractively priced relative to earnings

Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Areas to Watch

RDGT4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$55.41M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-8.0%2/10

ROE of -8.0% — below average capital efficiency

Revenue GrowthGrowth
-11.7%2/10

Revenue declined 11.7%

SCNX4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$19.69M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-24.1%2/10

ROE of -24.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : RDGT

The strongest argument for RDGT centers on Price/Book.

Bull Case : SCNX

The strongest argument for SCNX centers on P/E Ratio, Price/Book.

Bear Case : RDGT

The primary concerns for RDGT are EPS Growth, Market Cap, Return on Equity.

Bear Case : SCNX

The primary concerns for SCNX are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

RDGT profiles as a declining stock while SCNX is a value play — different risk/reward profiles.

SCNX is growing revenue faster at 8.1% — sustainability is the question.

RDGT generates stronger free cash flow (5M), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

RDGT scores higher overall (34/100 vs 33/100). SCNX offers better value entry with a 91.2% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ridgetech, Inc.

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

China Jo-Jo Drugstores, Inc. is a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company is headquartered in Hangzhou, the People's Republic of China.

Visit Website →

Scienture Holdings, Inc.

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Scienture Holdings, Inc. (SCNX) is an innovative biotechnology company focused on developing cutting-edge therapeutic solutions for neurological disorders. With a robust drug development pipeline supported by advanced technology and a highly skilled research team, Scienture is committed to meeting unmet medical needs and improving patient outcomes. The company's strategic emphasis on scientific excellence, regulatory compliance, and collaborative partnerships positions it well for growth within the burgeoning healthcare sector, highlighting its potential to make significant contributions to global health advancements.

Want to dig deeper into these stocks?